Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis Therapy
New findings from University Hospital in the area of arthritis therapy described
January 29th, 2007
Investigators publish new data in the report "Is IL-1 a good therapeutic target in the treatment of arthritis. Inflammation is an important homeostatic mechanism that limits the effects of infectious agents. However, inflammation might be self-damaging and therefore has to be tightly controlled or even abolished by the organism," scientists writing in the journal Bailliere's Best Practice and Research In Clinical Rheumatology report. "Interleukin 1 (IL-1) is a crucial mediator of the inflammatory response, playing an important part in the body's natural responses and the development of pathological conditions leading to chronic inflammation. While IL-1 production...
Source: Biotech Business Week (2007-01-29)
|
